Patent & IP news for August 31, 2014

A matter of life and death? No, it's more important than that. Life sciences in the limelight from ipkitten.blogspot.com

Shakespeare's three witches in Macbeth: 
life sciences, but no available patents ...If you ever want evidence of the enthusiasm of intellectual property practitioners for patents, you need look no further than this weblog. While ...

Share via E–mail | Twitter | Facebook

CBS Sunday Morning on August 31, 2014 from ipbiz.blogspot.com

Lee Cowan sits in for Charles Osgood. The cover story is by Martha Teichner. Forbes: best companies to work for. What workers really want. Second, Ather Hussein cameraman from Iraq. Third, Serena Altschul on Christopher ...

Share via E–mail | Twitter | Facebook

If your patent says something is “essential,” then it must be so. from ipspotlight.com

When providing a patent attorney with a written description of the invention, inventors and researchers often provide their patent attorney a copy of a manuscript for an upcoming technical journal, research publication or white paper ...

Share via E–mail | Twitter | Facebook

Washington Times reports on Ruichuan IPR Funds: the deck may be stacked against American companies in China from ipbiz.blogspot.com

A Washington Times post begins:



When the Chinese government announced in April it was establishing a government-controlled patent-operations fund in April, there were few people besides Asian trade analysts who gave the news much attention ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

September 4, 2014 - "Patents and Export Control Compliance: Managing Risk and Avoiding Unintentional Violations -- Minimizing Export Control Liability in Patent Application Preparation, Development and Analysis of Innovation, and Licensing" (Strafford) - 1:00 to 2:30 ...

Share via E–mail | Twitter | Facebook

Court Report from www.patentdocs.org

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AstraZeneca AB v. Watson Laboratories Inc. et al. 1:14-cv-01051; filed August 15, 2014 in the ...

Share via E–mail | Twitter | Facebook